BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE Drug Patent Profile
When do Bismuth Subsalicylate, Metronidazole And Tetracycline Hydrochloride patents expire, and what generic alternatives are available?
Bismuth Subsalicylate, Metronidazole And Tetracycline Hydrochloride is a drug marketed by Ailex Pharms Llc and is included in one NDA.
The generic ingredient in BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE is bismuth subsalicylate; metronidazole; tetracycline hydrochloride. There is one drug master file entry for this compound. Additional details are available on the bismuth subsalicylate; metronidazole; tetracycline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE?
- What are the global sales for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE?
- What is Average Wholesale Price for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE?
Summary for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 4 |
| DailyMed Link: | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Akil Al Islam | NA |
| Azfar Farogh | PHASE4 |
| Federal University of São Paulo | Phase 4 |
See all BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE clinical trials
US Patents and Regulatory Information for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ailex Pharms Llc | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | bismuth subsalicylate; metronidazole; tetracycline hydrochloride | TABLET, CHEWABLE, TABLET, CAPSULE;ORAL | 202584-001 | Nov 30, 2018 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
